NME1 and hepatocellular carcinoma: GAAD+US showed the highest rate of early detection with 64.9% of HCC cases at early-stage, followed by GAAD (62.2%), AFP+PIVKA-II (61.4%), AFP (57.2%), PIVKA-II (57.0%), AFP+US (56.7%) and US (48.3%).